Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)
CUSIP: 28658R106
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 68,580,003
- Total 13F shares
- 16,853,724
- Share change
- +125,134
- Total reported value
- $45,505,627
- Price per share
- $2.70
- Number of holders
- 22
- Value change
- +$348,407
- Number of buys
- 7
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 28658R106?
CUSIP 28658R106 identifies CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28658R106:
Top shareholders of CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AI ETI LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,009,400
|
$62,617,500 | — | 12 Aug 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
19%
|
13,150,849
|
$34,586,733 | — | 30 Sep 2023 | |
| BML Capital Management, LLC |
13F
|
Company |
2.8%
|
1,938,263
|
$5,097,632 | — | 30 Sep 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
811,680
|
$2,134,718 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.45%
|
309,821
|
$814,829 | — | 30 Sep 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
121,110
|
$318,519 | — | 30 Sep 2023 | |
| Atom Investors LP |
13F
|
Company |
0.12%
|
78,886
|
$207,470 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
66,626
|
$175,952 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
58,336
|
$154,007 | — | 30 Sep 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
55,223
|
$145,789 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
31,311
|
$82,347 | — | 30 Sep 2023 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.04%
|
29,704
|
$78,122 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
21,700
|
$57,288 | — | 30 Sep 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
14,650
|
$38,529 | — | 30 Sep 2023 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.02%
|
12,806
|
$32,785 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
11,182
|
$29,409 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
8,333
|
$21,915 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,896
|
$10,246 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,709
|
$4,495 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,390
|
$3,656 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
981
|
$2,590 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
89
|
$234 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
45
|
$118 | — | 30 Sep 2023 | |
| Robert Azelby |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
500,000
|
— | — | 31 Oct 2022 | |
| Erin Lavelle |
3/4/5
|
COO & CFO |
—
class O/S missing
|
170,000
|
— | — | 31 Oct 2022 | |
| James B. Bucher |
3/4/5
|
EVP and General Counsel |
—
class O/S missing
|
95,000
|
— | — | 31 Oct 2022 | |
| Leone D. Patterson |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 19 May 2022 |
Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q4 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.